10 Oct 2025

"LBO France Sells Stake in Serapid to Capital Croissance and Co-Investors to Accelerate Growth"

"Jeantet advised LBO France on the sale of its stake in Serapid, a specialist in rigid chain technology for heavy load movement, to Capital Croissance and its co-investors. Capital Croissance acquired a majority stake in Serapid alongside its executives, who are also reinvesting. This transaction aims to accelerate Serapid's development through organic growth and market expansion, particularly in the nuclear sector and internationally. LBO France, which entered Serapid in 2017, has supported the company's market positioning and expansion efforts. Capital Croissance focuses on supporting the growth of SMEs and mid-sized companies."

**Law Firms Involved in the Transaction:** Jeantet advised LBO France in the sale of its stake in Serapid to Capital Croissance and its co-investors. **Transaction Overview:** LBO France sold its participation in Serapid, a specialist in rigid chain technology for the movement of heavy loads, to Capital Croissance, which has taken a majority stake alongside the company's executives, Emeric Labesse (CEO) and Guillaume Davies (COO), who are also reinvesting. The investment round is further supported by the Fonds France Nucléaire 2, managed by Siparex, BNP Paribas Développement, and Unexo, a subsidiary of the Regional Banks of Crédit Agricole. This marks the fifth operation of the CAIRN Capital III fund, which raised €285 million at the end of 2023. The transaction aims to accelerate Serapid's development through organic growth driven by its unique patented innovation in the elevator market, expanding into new industrial markets, particularly in nuclear sectors, and continuing its international expansion. **Legal Team:** The Jeantet team included: - Pascal Georges (Partner, Corporate) - Marie Noppe (Associate, Corporate) - Nicolas Méheust (Associate, Corporate) - Gabriel di Chiara (Partner, Tax) - François-Xavier Simeoni (Counsel, Tax) - Hugo Cherqui (Associate, Tax)
Read the full story

Register for free to access daily news.

Register Free
We use cookies to improve your experience, analyze traffic, and serve targeted ads. Read our Cookie Policy.

Cookie Preferences

Customize your cookie settings. Necessary cookies are always enabled.

Strictly Necessary

Required for the website to function (e.g. login, security).

Analytics & Statistics

Help us understand how visitors interact with the website.

Marketing & Ads

Used to deliver relevant ads and track effectiveness.